Is Europe ready to transition towards artificial intelligence and digital health? What are the pros and cons of using AI in medicine? And what should be the role of healthcare professionals and experts in this transition?
On 26 October, the FEAM European Biomedical Policy Forum, with the support of AstraZeneca and the European Infrastructure for Translational Medicine (EATRIS), will hold its Annual Lecture on ‘Digital Health and AI: Benefits and Costs of Data Sharing in the EU’, in the search for answers to these questions.
Professor Luis Marti-Bonmati, FEAM Board Member and AI expert lead will be one of the participants in this discussion. In preparation for the event, FEAM interviewed him to find out his view on the subject.
In this interview, the also Director of the Medical Imaging Clinical Area at the University and Polytechnic Hospital La Fe (Valencia, Spain) stresses that “no AI solution without the involvement of medical doctors will have a real impact” and that with the digital transtion will also come several challenges, but “we have to not only take care of that but also try to maximize the pros and minimize the cons”.
Watch the full interview here:
